Hydroxylation of warfarin by human cDNA-expressed cytochrome P-450: a role for P-4502C9 in the etiology of (S)-warfarin-drug interactions
- Journal
- Chemical Research in Toxicology
In The Last Decade
doi.org/10.1021/tx00025a009 →Countries where authors are citing Hydroxylation of warfarin by human cDNA-expressed cytochrome P-450: a role for P-4502C9 in the etiology of (S)-warfarin-drug interactions
This map shows the geographic impact of Hydroxylation of warfarin by human cDNA-expressed cytochrome P-450: a role for P-4502C9 in the etiology of (S)-warfarin-drug interactions. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hydroxylation of warfarin by human cDNA-expressed cytochrome P-450: a role for P-4502C9 in the etiology of (S)-warfarin-drug interactions with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hydroxylation of warfarin by human cDNA-expressed cytochrome P-450: a role for P-4502C9 in the etiology of (S)-warfarin-drug interactions more than expected).
Fields of papers citing Hydroxylation of warfarin by human cDNA-expressed cytochrome P-450: a role for P-4502C9 in the etiology of (S)-warfarin-drug interactions
This network shows the impact of Hydroxylation of warfarin by human cDNA-expressed cytochrome P-450: a role for P-4502C9 in the etiology of (S)-warfarin-drug interactions. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the Hydroxylation of warfarin by human cDNA-expressed cytochrome P-450: a role for P-4502C9 in the etiology of (S)-warfarin-drug interactions.
About Hydroxylation of warfarin by human cDNA-expressed cytochrome P-450: a role for P-4502C9 in the etiology of (S)-warfarin-drug interactions
This paper, published in 1992, received 494 indexed citations . Written by Allan E. Rettie, Kenneth R. Korzekwa, Kent L. Kunze, Ross F. Lawrence, A. Craig Eddy, Toshifumi Aoyama, Harry V. Gelboin, Frank J. Gonzalez and William Trager covering the research area of Molecular Biology and Pharmacology. It is primarily cited by scholars working on Pharmacology (426 citations), Oncology (142 citations) and Endocrinology, Diabetes and Metabolism (94 citations). Published in Chemical Research in Toxicology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
This paper is also available at doi.org/10.1021/tx00025a009.